Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson's Disease.
Animals
Axonal Transport
Brain Chemistry
Dopaminergic Neurons
/ metabolism
Duodenum
/ innervation
Humans
Injections, Intramuscular
Lewy Bodies
/ metabolism
Maze Learning
Memory Disorders
/ etiology
Mice
Mice, Inbred C57BL
Mice, Knockout
Models, Neurological
Muscle, Smooth
/ innervation
Nesting Behavior
/ physiology
Parkinsonian Disorders
/ etiology
Phosphorylation
Protein Aggregates
Protein Processing, Post-Translational
Pylorus
/ innervation
Rotarod Performance Test
Vagotomy
Vagus Nerve
/ metabolism
alpha-Synuclein
/ administration & dosage
Braak hypothesis
Lewy body pathology
Parkinson’s disease
gut to brain transmission
motor symptoms
neurodegeneration
non-motor symptoms
pre-formed fibrils
vagus nerve
α-synuclein
Journal
Neuron
ISSN: 1097-4199
Titre abrégé: Neuron
Pays: United States
ID NLM: 8809320
Informations de publication
Date de publication:
21 08 2019
21 08 2019
Historique:
received:
24
07
2018
revised:
03
04
2019
accepted:
22
05
2019
pubmed:
1
7
2019
medline:
29
10
2019
entrez:
1
7
2019
Statut:
ppublish
Résumé
Analysis of human pathology led Braak to postulate that α-synuclein (α-syn) pathology could spread from the gut to brain via the vagus nerve. Here, we test this postulate by assessing α-synucleinopathy in the brain in a novel gut-to-brain α-syn transmission mouse model, where pathological α-syn preformed fibrils were injected into the duodenal and pyloric muscularis layer. Spread of pathologic α-syn in brain, as assessed by phosphorylation of serine 129 of α-syn, was observed first in the dorsal motor nucleus, then in caudal portions of the hindbrain, including the locus coeruleus, and much later in basolateral amygdala, dorsal raphe nucleus, and the substantia nigra pars compacta. Moreover, loss of dopaminergic neurons and motor and non-motor symptoms were observed in a similar temporal manner. Truncal vagotomy and α-syn deficiency prevented the gut-to-brain spread of α-synucleinopathy and associated neurodegeneration and behavioral deficits. This study supports the Braak hypothesis in the etiology of idiopathic Parkinson's disease (PD).
Identifiants
pubmed: 31255487
pii: S0896-6273(19)30488-X
doi: 10.1016/j.neuron.2019.05.035
pmc: PMC6706297
mid: NIHMS1530676
pii:
doi:
Substances chimiques
Protein Aggregates
0
Snca protein, mouse
0
alpha-Synuclein
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Video-Audio Media
Langues
eng
Sous-ensembles de citation
IM
Pagination
627-641.e7Subventions
Organisme : NINDS NIH HHS
ID : P50 NS038377
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS082205
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS107404
Pays : United States
Organisme : NINDS NIH HHS
ID : R21 NS098006
Pays : United States
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Type : CommentIn
Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.
Références
EMBO Mol Med. 2013 Jul;5(7):1119-27
pubmed: 23703938
Regul Pept. 2000 Mar 17;88(1-3):15-20
pubmed: 10706947
Neurobiol Dis. 2018 Apr;112:106-118
pubmed: 29341898
Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):20051-6
pubmed: 19892735
Ann N Y Acad Sci. 2009 Jul;1170:615-22
pubmed: 19686202
Mov Disord. 2017 Oct;32(10):1487-1491
pubmed: 28681931
J Neurol. 2008 Sep;255 Suppl 5:39-47
pubmed: 18787881
Sci Rep. 2016 Jun 06;6:27358
pubmed: 27264956
Nat Neurosci. 2014 Aug;17(8):1022-30
pubmed: 25065439
Hippocampus. 2015 Nov;25(11):1242-9
pubmed: 25675878
Nat Cell Biol. 2002 Feb;4(2):160-4
pubmed: 11813001
Prog Neuropsychopharmacol Biol Psychiatry. 2010 Aug 16;34(6):1104-14
pubmed: 20547199
J Exp Med. 2016 Nov 14;213(12):2635-2654
pubmed: 27810929
Nat Med. 2004 Oct;10(10):1055-63
pubmed: 15459709
Mov Disord. 2014 Jul;29(8):1010-8
pubmed: 24395122
FEMS Microbiol Ecol. 2018 Jul 1;94(7):
pubmed: 29790946
Ann Neurol. 2015 Dec;78(6):1011-2
pubmed: 26418122
J Exp Med. 2016 Aug 22;213(9):1759-78
pubmed: 27503075
Cell Tissue Res. 2004 Oct;318(1):121-34
pubmed: 15338272
J Biol Chem. 2016 Sep 2;291(36):18675-88
pubmed: 27382062
Neuron. 2012 Jun 7;74(5):858-73
pubmed: 22681690
Nat Rev Neurosci. 2017 Jan 20;18(2):101-113
pubmed: 28104909
Science. 2012 Nov 16;338(6109):949-53
pubmed: 23161999
Hippocampus. 2016 Jan;26(1):76-86
pubmed: 26174222
Sci Rep. 2018 Sep 21;8(1):14173
pubmed: 30242292
Bio Protoc. 2016 Jun 5;6(11):
pubmed: 29119127
Nat Protoc. 2006;1(2):848-58
pubmed: 17406317
Sci Rep. 2017 Sep 11;7(1):11244
pubmed: 28894128
Adv Neurol. 1990;53:163-6
pubmed: 2239456
Science. 2016 Sep 30;353(6307):
pubmed: 27708076
Pharmacol Biochem Behav. 1986 Mar;24(3):525-9
pubmed: 2871560
Cell Mol Neurobiol. 2002 Jun;22(3):227-37
pubmed: 12469866
Sci Rep. 2014 May 02;4:4874
pubmed: 24786396
Acta Neuropathol. 2014 Dec;128(6):805-20
pubmed: 25296989
Ann Neurol. 2004 Aug;56(2):173-81
pubmed: 15293269
Behav Brain Res. 2010 Jul 29;211(1):1-10
pubmed: 20211655
Neurobiol Aging. 2003 Mar-Apr;24(2):197-211
pubmed: 12498954
Mol Neurodegener. 2018 May 11;13(1):21
pubmed: 29751824
Front Syst Neurosci. 2011 May 18;5:31
pubmed: 21647359
Eur J Neurosci. 2008 Jul;28(2):247-56
pubmed: 18702696
Nat Protoc. 2006;1(3):1306-11
pubmed: 17406415
Dialogues Clin Neurosci. 2006;8(2):163-74
pubmed: 16889103
J Neurosci. 2004 Oct 20;24(42):9434-40
pubmed: 15496679
J Neural Transm (Vienna). 2003 May;110(5):517-36
pubmed: 12721813
Am J Physiol. 1991 Jan;260(1 Pt 2):R200-7
pubmed: 1992820
Lancet Neurol. 2009 May;8(5):464-74
pubmed: 19375664
Brain Res Bull. 2002 May;58(1):41-7
pubmed: 12121811
JCI Insight. 2017 Jun 15;2(12):
pubmed: 28614796
Eur J Pharmacol. 2009 Oct 1;619(1-3):44-9
pubmed: 19666019
Nat Protoc. 2014 Sep;9(9):2135-46
pubmed: 25122523
Neurosci Biobehav Rev. 2005;29(4-5):571-625
pubmed: 15890404
Lab Invest. 2019 Jul;99(7):971-981
pubmed: 30760864
Science. 2002 Feb 1;295(5556):851-5
pubmed: 11823641
Neuroscience. 1991;45(1):153-60
pubmed: 1684412
Psychopharmacology (Berl). 1985;85(3):367-70
pubmed: 3923523
Sci Rep. 2015 Aug 20;5:13419
pubmed: 26289670
Cell. 2016 Dec 1;167(6):1469-1480.e12
pubmed: 27912057
Neuropathol Appl Neurobiol. 2007 Dec;33(6):599-614
pubmed: 17961138
Neurology. 2017 May 23;88(21):1996-2002
pubmed: 28446653
Nat Protoc. 2006;1(3):1117-9
pubmed: 17406392
Acta Neuropathol. 2010 Jul;120(1):1-12
pubmed: 20532896
Lancet Neurol. 2003 Feb;2(2):107-16
pubmed: 12849267
Nat Rev Gastroenterol Hepatol. 2012 Mar 06;9(5):286-94
pubmed: 22392290
Genes Brain Behav. 2010 Oct;9(7):712-21
pubmed: 20528954
Nat Rev Neurol. 2010 Dec;6(12):702-6
pubmed: 21045796
Hum Mol Genet. 2010 May 1;19(9):1633-50
pubmed: 20106867
PLoS One. 2010 Jan 19;5(1):e8762
pubmed: 20098733
Endocrinology. 2003 Dec;144(12):5184-7
pubmed: 14525914
Ann Neurol. 2015 Oct;78(4):522-9
pubmed: 26031848
Neuroscience. 2008 Oct 28;156(4):830-40
pubmed: 18817851
Eur Neuropsychopharmacol. 2018 Feb;28(2):307-316
pubmed: 29426666
J Neurosci. 2017 Jun 7;37(23):5699-5710
pubmed: 28495971
Clin Rehabil. 2015 Aug;29(8):741-51
pubmed: 25394397
Acta Neuropathol. 2007 Apr;113(4):421-9
pubmed: 17294202
Nat Rev Neurol. 2015 Nov;11(11):625-36
pubmed: 26503923
Eur J Pharmacol. 1978 Feb 15;47(4):379-91
pubmed: 204499
Sci Rep. 2012;2:898
pubmed: 23205266
PLoS One. 2011;6(12):e28032
pubmed: 22145021
Neuron. 2011 Oct 6;72(1):57-71
pubmed: 21982369
Brain Res Bull. 1980 Jul-Aug;5(4):365-73
pubmed: 7407633
Nat Neurosci. 2007 Sep;10(9):1116-24
pubmed: 17726478
J Biol Chem. 2006 Oct 6;281(40):29739-52
pubmed: 16847063